Literature DB >> 25083306

Safety implications of oesophageal stents used for the palliation of dysphagia in patients undergoing neoadjuvant therapy for oesophageal malignancy-authors' reply.

Vinayak Nagaraja1, Michael R Cox1, Guy D Eslick1.   

Abstract

Entities:  

Year:  2014        PMID： 25083306      PMCID： PMC4110499          DOI： 10.3978/j.issn.2078-6891.2014.043

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  8 in total

1.  A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer.

Authors:  J Shenfine; P McNamee; N Steen; J Bond; S M Griffin
Journal:  Health Technol Assess       Date:  2005-02       Impact factor: 4.014

2.  Self-expanding plastic stent removed after radiochemotherapy for advanced esophageal cancer.

Authors:  A Laquière; P Grandval; D Heresbach; F Prat; J P Arpurt; P Bichard; P-N D'Halluin; J Berthillier; C Boustière; R Laugier
Journal:  Dis Esophagus       Date:  2013-05-07       Impact factor: 3.429

3.  Evaluation of quality of life following placement of self-expanding plastic stents as a bridge to surgery in patients receiving neoadjuvant therapy for esophageal cancer.

Authors:  Robert C G Martin; Robert M Cannon; Russell E Brown; Susan F Ellis; Sharon Williams; C R Scoggins; Abbas E Abbas
Journal:  Oncologist       Date:  2014-02-24

4.  Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up.

Authors:  N A Christie; P O Buenaventura; H C Fernando; N T Nguyen; T L Weigel; P F Ferson; J D Luketich
Journal:  Ann Thorac Surg       Date:  2001-06       Impact factor: 4.330

5.  Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis.

Authors:  Vinayak Nagaraja; Michael R Cox; Guy D Eslick
Journal:  J Gastrointest Oncol       Date:  2014-04

6.  A pilot study of fully covered self-expandable metal stents prior to neoadjuvant therapy for locally advanced esophageal cancer.

Authors:  T L Lopes; M A Eloubeidi
Journal:  Dis Esophagus       Date:  2009-09-24       Impact factor: 3.429

7.  Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial.

Authors:  Hai-Dong Zhu; Jin-He Guo; Ai-Wu Mao; Wei-Fu Lv; Jian-Song Ji; Wen-Hui Wang; Bin Lv; Rui-Min Yang; Wei Wu; Cai-Fang Ni; Jie Min; Guang-Yu Zhu; Li Chen; Mei-Ling Zhu; Zhen-Yu Dai; Peng-Fei Liu; Jian-Ping Gu; Wei-Xin Ren; Rui-Hua Shi; Gao-Feng Xu; Shi-Cheng He; Gang Deng; Gao-Jun Teng
Journal:  Lancet Oncol       Date:  2014-04-14       Impact factor: 41.316

8.  Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy.

Authors:  Felix B Langer; Sebastian F Schoppmann; Gerhard Prager; Florian Tomaselli; Ursula Pluschnig; Michael Hejna; Rainer Schmid; Johannes Zacherl
Journal:  Ann Surg Oncol       Date:  2009-10-27       Impact factor: 5.344
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.